Medical Device | May 20, 2026
Shaily gets regulatory nod for launch of ShailyPen Neo device technology
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The Product is expected to be the first generic approval on the market
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
